MAFS, it is time for a reality check on solariums.
7 February 2020
Dear MAFS fans, we need to talk.
Who watched newly-wed Natasha last night rattling off her weekly ‘beauty’ routine to husband Mikey? ‘Botox, fillers, nails, hair…facials,massages, fat freezing, solarium…’
Please tell me I didn’t just hear ‘solarium’? Hearing a vibrant and educated 26 year old, with her life and world ahead of her, so casually mention her solarium use should have sent chills up your spine.
And this is why:
1. Solarium use greatly increases your risk of deadly melanoma – conclusive research on patients under 40 showed those who'd had more than 10 solarium visits in their life had up to a seven-times greater risk of developing melanoma.
2. Melanoma kills one Australian every five hours, and is the most common cancer affecting 15 to 39 year old Ausssies.
3. Commercial solariums are illegal across Australia – Melanoma Institute Australia research was integral in them being banned due to the clear link between solarium use and melanoma.
Natasha didn’t detail where she uses the solarium, but odds are there was one backyard operator sitting on their couch last night breathing a big sigh of relief that their illegal underground commercial sunbed operation wasn’t outed on national television.
Natasha’s weekly ‘beauty’ routine has today been discussed, dissected and debated online, on social media and on radio, mainly for laughs. But this is a serious issue, a potentially deadly one in fact.
The research is clear that whatever type of solarium you're using, in a home or an illegal backyard commercial operation - none of them are safe.
At a time when families across Australia are preparing to take part in Melanoma March events in memory of loved ones they have lost to melanoma, it was confronting, but most of all sad, to see a young woman choosing to put her health at risk for a tan.
It is time all Australians took melanoma seriously, including reality TV shows that air such comments so flippantly. Surely the lives of young Australians are more valuable than that.
Matthew Browne - CEO, Melanoma Institute Australia
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.